Neuronostics develop clinical decision support systems and at-home monitoring tools for neurological conditions
Neuronostics has raised $2.7M in total funding. The most recent round was Seed. The last funding was announced in April 2024.
Neuronostics's investors include Innovate UK, Cornwall & Isles of Scilly Investment Fund, Empirical Ventures, The FSE Group, QantX.
Neuronostics is headquartered in Bristol, United Kingdom.
Neuronostics develop clinical decision support systems and at-home monitoring tools for neurological conditions
Neuronostics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neuronostics — Funding & Investors." VCBacked, April 5, 2024, https://www.vcbacked.co/company/neuronostics. Accessed July 21, 2026.
VCBacked. (2024). Neuronostics — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/neuronostics
{{cite web |title=Neuronostics — Funding & Investors |url=https://www.vcbacked.co/company/neuronostics |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated